ArticleThe Journal of experimental medicine2022

PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen.

Mingyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.